# Association of serum 25-hydroxyvitamin D concentrations with all-cause and cardiovascular mortality among US adults with prehypertension: a prospective cohort study

**Authors:** Yongmei Zhou, Yu Chen, Fuli Chen, Gang Li, Long Zhou

PMC · DOI: 10.1186/s41043-024-00515-5 · Journal of Health, Population, and Nutrition · 2024-02-06

## TL;DR

Low vitamin D levels in people with prehypertension are linked to higher risks of death from all causes and heart disease.

## Contribution

First study to examine the link between vitamin D levels and mortality in prehypertensive adults.

## Key findings

- Severe vitamin D deficiency was associated with a 2.83 times higher risk of all-cause mortality.
- Each 10 nmol/L increase in vitamin D reduced all-cause and CVD mortality risks by 9% and 14%, respectively.
- Vitamin D supplementation may help prevent premature death in severely deficient prehypertensive individuals.

## Abstract

Prehypertension affects 25–50% of adults worldwide and no prior study has examined the relationship between serum 25-hydroxyvitamin D [25(OH)D] concentrations and mortality risk in individuals with prehypertension. This study aims to investigate the association of serum 25(OH)D concentrations with all-cause and CVD mortality among prehypertensive adults by utilizing data from the US National Health and Nutrition Examination Survey (NHANES) 2007–2014 and linked 2019 mortality file.

We included 4345 prehypertensive adults who participated in the NHANES between 2007 and 2014 and were followed up until 31 December 2019. Weighted Cox proportional hazards models were used with adjustments for multiple covariates to calculate the hazard ratio (HR) and 95% confidence interval (CI) for the risks of dying from any cause and CVD.

During a median follow-up of 8.8 years, 335 deaths from any causes were documented, of which 88 participants died from CVD. Compared with participants with sufficient 25(OH)D (≥ 75 nmol/L), the multivariate-adjusted HRs and 95% CIs for participants with severe deficiency (< 25 nmol/L), moderate deficiency (25–49.9 nmol/L), and insufficient concentrations (50–74.9 nmol/L) of serum 25(OH)D for all-cause death were 2.83 (1.46–5.52), 1.17 (0.74–1.86), and 1.36 (0.93–1.98), respectively. Similarly, the multivariable-adjusted HRs and 95%CIs for CVD death were 4.14 (1.10–15.51), 1.23 (0.46–3.28), and 1.73 (0.96–3.14), respectively. We found that there was a 9% reduction in the risk of death from all causes and a 14% reduction in the risk of death from CVD for every 10 nmol/L increase in serum 25(OH)D concentrations.

Severe serum 25(OH)D deficiency among prehypertensive adults was associated with increased risk of mortality from all causes as well as from CVD. Our work suggests that supplementing with vitamin D may prevent premature death in severely deficient individuals with prehypertension.

The online version contains supplementary material available at 10.1186/s41043-024-00515-5.

## Linked entities

- **Chemicals:** 25-hydroxyvitamin D (PubChem CID 5353325)
- **Diseases:** cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Diseases:** CVD death (MESH:D003643), Prehypertension (MESH:D058246)
- **Chemicals:** vitamin D (MESH:D014807), 25(OH)D (-), 25-hydroxyvitamin D (MESH:C104450)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10848370/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10848370/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC10848370/full.md

---
Source: https://tomesphere.com/paper/PMC10848370